Mythili Koneru
2021
In 2021, Mythili Koneru earned a total compensation of $901.5K as Chief Medical Officer at TapImmune, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,311 |
|---|---|
| Option Awards | $351,400 |
| Salary | $405,827 |
| Total | $901,538 |
Koneru received $405.8K in salary, accounting for 45% of the total pay in 2021.
Koneru also received $144.3K in non-equity incentive plan and $351.4K in option awards.
Rankings
In 2021, Mythili Koneru's compensation ranked 9,111th out of 12,415 executives tracked by ExecPay. In other words, Koneru earned more than 26.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,111 out of 12,415 | 27th |
Division Manufacturing | 4,042 out of 5,508 | 27th |
Major group Chemicals And Allied Products | 1,780 out of 2,378 | 25th |
Industry group Drugs | 1,582 out of 2,099 | 25th |
Industry Pharmaceutical Preparations | 1,177 out of 1,549 | 24th |
Source: SEC filing on April 15, 2022.
Koneru's colleagues
We found two more compensation records of executives who worked with Mythili Koneru at TapImmune in 2021.